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Abstract 
This review examines the available evidence for targeting a specific mean arterial pressure (MAP) in sepsis resuscita-
tion. The clinical data suggest that targeting an MAP of 65–70 mmHg in patients with septic shock who do not have 
chronic hypertension is a reasonable first approximation. Whereas in patients with chronic hypertension, targeting a 
higher MAP of 80–85 mmHg minimizes renal injury, but it comes with increased risk of arrhythmias. Importantly, MAP 
alone should not be used as a surrogate of organ perfusion pressure, especially under conditions in which intracranial, 
intra-abdominal or tissue pressures may be elevated. Organ-specific perfusion pressure targets include 50–70 mmHg 
for the brain based on trauma brain injury as a surrogate for sepsis, 65 mmHg for renal perfusion and >50 mmHg 
for hepato-splanchnic flow. Even at the same MAP, organs and regions within organs may have different perfusion 
pressure and pressure–flow relationships. Thus, once this initial MAP target is achieved, MAP should be titrated up or 
down based on the measures of organ function and tissue perfusion.
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Background
In 1969, Weil and Shubin emphasized the importance of 
fluid resuscitation followed by cardiovascular support 
with vasoactive agents for the treatment of shock [1]. 
This strategy is still the mainstay of management of septic 
shock today [2]. The Surviving Sepsis Campaign Guide-
lines recommend initial resuscitation by fluid administra-
tion, at least with 30 ml/kg of crystalloids, followed by use 
of vasoactive agent such as norepinephrine for the treat-
ment of patients with septic shock [3]. Hypotenison can 
be defined as a systolic arterial pressure  <90  mmHg, a 
mean arterial pressure (MAP) <65 mmHg or a decrease in 
MAP >40 mmHg in a previously hypertensive patient [4].
Although this strategy has been well established, blood 
pressure target in septic shock patients remains a subject 
of ongoing controversy. The Surviving Sepsis Campaign 
Guidelines recommend MAP target of 65  mmHg as a 
starting point [3], but this recommendation is based on 
limited evidence. The guidelines caution that the MAP 
target should be individualized because older patients 
with atherosclerosis or previous hypertension, for exam-
ple, may have a higher optimal MAP than younger 
patients without any cardiovascular conditions.
In 2004, Asfar et  al. conducted a multicenter, rand-
omized, open-label, prospective study involving 776 
septic shock patients in French intensive care units 
(ICU) [5]. The study confirmed that targeting an MAP of 
65–70  mmHg in a patient without prior chronic hyper-
tension was a reasonable first approximation. In a patient 
with a history of chronic hypertension, however, target-
ing an MAP of 80–85 mmHg was associated with lower 
incidences of AKI and the need for renal replacement 
therapy. Although patients with chronic hypertension 
benefited from this higher MAP target, it was associated 
with higher incidences of adverse events such as tachyar-
rhythmia, presumably because higher doses and duration 
of vasopressors were necessary.
Taken together, the available evidence underscores 
the importance of personalizing the MAP target based 
on clinical responses of individual patients with sep-
tic shock. Heterogeneity, not only of patients, but their 
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individual organs and microcirculation [6, 7] makes uni-
form approach to septic shock particularly difficult. The 
aim of this review, therefore, is to provide some guidance 
on how to personalize management of blood pressure in 
patients with septic shock. We reviewed the existing lit-
eratures using both PubMed and Google Scholar search 
engines for the primary search terms: arterial blood pres-
sure, sepsis, severe sepsis, septic shock, perfusion pres-
sure, critical closing pressure and autoregulation. We then 
expanded our search as linked citations indicated. We 




Humans, like other warm-blooded animals, maintain rel-
atively high blood pressure at the expense of its multiple 
potentially negative consequences, such as myocardial 
ischemia, atherosclerosis, aneurysm or chronic kidney 
disease. This is because high blood pressure is necessary 
to allow autoregulation of organ blood flow to occur.
Autoregulation is defined as the intrinsic ability of 
organs to maintain a constant blood flow despite changes 
in perfusion pressure [8]. Since organs autoregulate their 
blood flow to meet their metabolic demands, this dis-
sociation between pressure and flow seems reasonable. 
Organ blood flow and cardiac output (CO) are usually 
independent of arterial blood pressure except under 
extreme hypo- and hypertension.
Organs can increase their own individual blood flow 
to meet their changing metabolic demands primarily by 
decreasing resistance, or vasodilation. Accordingly, both 
inflow pressure and intra-organ inflow resistance at the 
baseline must be sufficiently high to leave sufficient room 
for autoregulation of organ blood flow to occur. As a cor-
ollary, hypotension alone impairs local autoregulation 
independent of other factors like vasomotor tone and 
vascular responsiveness because without a sufficiently 
high inflow pressure, changes in local vascular resistance 
will not result in changes in local blood flow.
Organ perfusion pressure is the difference between 
the inflow pressure and outflow pressure. In a totally 
vasodilated vasculature, outflow pressure approximates 
local venous pressure. Inflow and outflow pressures dif-
fer across vascular beds and can be altered by various 
diseases (Table  1). Although MAP is usually considered 
to be the inflow pressure, actual arterial inflow pressure 
varies greatly across organs. For example, arterial inflow 
pressure at porta hepatis is about 10–30  mmHg lower 
than MAP because of high hepatic arterial resistance. 
Similarly, renal perfusion pressure of the post-glomerular 
tubules is much lower than MAP and varies greatly based 
on solute load. Outflow pressure is not uniform across 
organs either. Global renal perfusion pressure, which is 
the difference between MAP and central venous pressure 
(CVP), becomes the difference between MAP and intra-
abdominal pressure (IAP) when IAP is elevated, such as 
in intra-abdominal hypertension or abdominal compart-
ment syndrome.
Under normal conditions, distribution of organ blood 
flow is determined by local metabolic demands. For 
example, cerebral blood flow increases in the cortex 
when the mind is actively thinking [9], and splanch-
nic blood flow at the site of peristalsis and absorption 
increases after a meal [10]. Actively metabolizing tissues 
are thought to increase blood flow by releasing vasoac-
tive substances such as adenosine, a potent vasodilator 
[11]. In contrast, under hypotensive conditions, organ 
blood flow is no longer determined by local metabolic 
demands, but is redistributed according to each organ’s 
pressure–flow relationship under maximally vasodilated 
conditions.
This is because autoregulation, though central for 
normal blood flow homeostasis, is overruled in circula-
tory shock where baroreceptor-induced hypotension 
induces profound sympathetic nervous system output. 
Thus, in circulatory shock, sympathetic-induced vaso-
constriction, not the metabolic-related vasoconstric-
tion, becomes the primary determinant of organ blood 
flow distribution. The massive sympathetic discharge 
causes α-adrenergic receptor-based vascular vasocon-
striction to occur as a function of the amount of vascu-
lar α-adrenergic receptor density and responsiveness of a 
given vascular region. Skin and skeletal muscle have large 
Table 1 Perfusion pressure for different organs
MAP mean arterial pressure, BP blood pressure, CVP central venous pressure
Organs Inflow pressure Outflow pressure (whichever is higher) Perfusion pressure
Brain MAP CVP or intracranial pressure (ICP) MAP—CVP or ICP
Heart Diastolic BP CVP or intrathoracic pressure (ITP) Diastolic BP—CVP or ITP
Kidney MAP CVP or intra-abdominal pressure (IAP) MAP—CVP or IAP
Bowel MAP CVP or intra-abdominal pressure (IAP) MAP—CVP or IAP
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concentrations of α-adrenergic receptors and constrict 
markedly in response to circulatory shock. The gut has 
less α-adrenergic receptors and the kidneys lesser still. 
Importantly, the heart has minimal α-adrenergic recep-
tors and the cerebral circulation none. Therefore, in case 
of severe systemic hypotension, organ blood flow will be 
diverted away from the skin, non-exercising skeletal mus-
cles and splanchnic viscera to support the brain, heart 
and kidney blood flow [8]. This redistribution of blood 
flow not only ensures adequate blood flow to these criti-
cal organs, but also increases the net efficiency of O2 uti-
lization of a whole body [12]. Importantly, during septic 
shock, adrenergic hypo-responsiveness often occurs 
owing to internalization of adrenergic receptors and 
inflammatory mediator-induced release of potent vaso-
active agents (e.g., nitric oxide). The resultant combina-
tion of systemic hypotension and vasoplegia blunts the 
normal redistribution of blood flow usually seen in circu-
latory shock and markedly limits the host’s ability to sus-
tain the vital organ blood flow. If the perfusion pressure 
falls below the autoregulation threshold where blood ves-
sels are already maximally dilated, organ blood flow will 
decrease linearly to declines in perfusion pressure.
Under normal conditions, if inflow pressure were to be 
abruptly decreased, organ blood flow would also decrease 
and then cease at an inflow pressure higher than outflow 
venous pressure. This organ-specific stop-flow pressure 
is called critical closing pressure (Pcc) and it was first 
proposed by Burton [13]. Pcc is generated by vasomo-
tor tone of arterioles and pre-capillary sphincters. As a 
lump sum, Pcc is thought to be around 45 mmHg in nor-
mal healthy adults [14], but it can vary among vascular 
beds dependent upon the overall sympathetic tone and 
local metabolic demands. As local vasodilation increases, 
Pcc decreases toward outflow pressure (Fig. 1). Notably, 
in the heart, which is maximally extracting oxygen at all 
times, Pcc is only slightly higher than CVP and the pri-
mary way the coronary circulation can increase its flow is 
by vasodilation [15–17].
Under normal resting conditions, perfusion pressure is 
the difference between inflow pressure and Pcc, and out-
flow venous pressure does not influence organ blood flow 
[18]. This phenomenon is called “vascular waterfall.” The 
principle of vascular waterfall is that flow over the edge 
of the waterfall is independent on how far the water then 
drops toward the pool below (Fig. 2). Local tissue Pcc is 
analogous to the waterfall edge and central venous pres-
sure (CVP) to the downstream pool, such that changes in 
CVP will have no impact on the flow or resistance. There-
fore, while CVP is necessary in calculating organ perfu-
sion pressure, CVP should not guide treatment decisions 
in patients with septic shock. Maas et al. confirmed the 
existence of a vascular waterfall by showing a significant 
difference between Pcc and mean systemic filling pres-
sure (Pmsf) in post-cardiac surgery patients [14]. This 
difference signified the height of vascular waterfall.
It is critically important to identify patients whose 
perfusion pressure is below the autoregulation thresh-
old because from the point downward, organ blood flow 
is usually inadequate and organ perfusion will solely 
depend on perfusion pressure. This is the rationale for 
using vasopressors to restore organ perfusion pressure 
during acute resuscitation in fluid resuscitated patients 
with septic shock. Regrettably, there is not one threshold 
MAP because each organ system has a different inflow 
and outflow pressures and internal control systems linked 
to their individual physiologic roles [19]. For example, 
the kidney increases filtration as renal perfusion pres-
sure increases because its role is to filter solute from the 
blood, whereas the liver maintains a relatively constant 
flow from the combined hepatic artery and portal vein so 
as to maintain hepatic clearance and metabolic functions.
Clinical evidence
Although the Surviving Sepsis Guidelines recommend 
using vasopressor to support an initial MAP target of 
65  mmHg followed by individualized titration [3], this 
Perfusion Pressure (PP) 
Flow (Q) 
Crical Closing Pressure 
Maximal Vasodilaon 
Maximal Vasoconstricon 
Fig. 1 Theoretical relationship between arterial input pressure (P) 
and blood flow (Q) for a given vascular bed or the entire body. The 
thick solid line represents the actual relationship between pressure 
and flow describing the autoregulation of vascular tone to sustain 
a constant blood flow despite varying arterial input pressures. The 
smaller straight lines reflect the theoretical instantaneous arterial input 
pressure to blood flow relations that exist upon this autoregulation 
curve showing how changes in vascular tone from maximal vasocon-
striction (far left) to maximal vasodilation (far right) account for this 
phenomenon. Note the zero blood flow intercept points, or critical 
closing pressure of the arterial input circuit also varies with changes 
in vasomotor tone such that both slope (resistance) and zero-flow 
intercept (critical closing pressure) co-vary as local vasomotor tone 
varies
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recommendation was based on limited evidence. A retro-
spective cohort study by Varpula et al. showed that MAP 
below 65  mmHg, particularly during the first 48  h in the 
ICU, was associated with the highest mortality in patients 
with septic shock [20]. Meanwhile, a small prospective 
study by LeDoux et al. showed no improvements in tissue 
perfusion by increasing MAP from 65 to 85 mmHg using 
norepinephrine [21], and a small randomized, open-label, 
prospective study by Bourgoin et al. also showed lack of any 
benefit by targeting an MAP higher than 65 mmHg [22].
Looking specifically at renal function, however, 
other studies found that targeting an MAP higher than 
70  mmHg might be beneficial [23, 25]. Furthermore, in 
reality, the majority of critical care practitioners seemed 
to be targeting an MAP higher than 65  mmHg [26]. 
Clearly, more studies were needed to determine the opti-
mal MAP in patients with septic shock.
In this context, Asfar et  al. conducted a multicenter, 
randomized, stratified, open-label study called the 
Assessment of Two Levels of Arterial Pressure on Sur-
vival in Patients with Septic Shock (SEPSISPAM) to 
determine whether targeting an MAP of 65–70  mmHg 
was more or less effective than targeting a higher MAP of 
80–85 mmHg [5]. Unfortunately, MAP values of the low-
MAP target group usually ranged from 70 to 75 mmHg 
and rarely decreased toward the 65  mmHg minimal 
threshold. Still, the study showed that there was no sig-
nificant between-group difference in the rate of death at 
28 and at 90  days. For the patients with chronic hyper-
tension, the low-MAP target group had a higher inci-
dence of the doubling of creatinine level and the need for 
renal replacement therapy.
Importantly, targeting a higher MAP in all patients was 
not without risk. Although this study was underpow-
ered to detect any differences in incidence of most of the 
adverse events, which were rare, the majority of adverse 
events (mainly tachyarrhythmias) were reported higher 
in the high-MAP target group who required higher infu-
sion rates and duration of vasopressors [5].
The study supports the recommendation that target-
ing an initial MAP of 65–70 mmHg in a patient without 
prior chronic hypertension is a reasonable first approxi-
mation, after which time MAP levels should be adjusted 
up or down as end-organ function dictates. Whereas in 
the patient with chronic hypertension, targeting a higher 
MAP around 80–85  mmHg appears to be a reasonable 
first step, but it should be done with caution because of 
the potential risk of adverse events due to higher doses 
and duration of vasopressors that would be necessary. 
Although no study to date has shown the impact of the 
dose and duration of vasopressors on survival, studies 
have consistently shown the risk of adverse events due to 
vasopressor use, ranging from 10 to 12 % [27–29].
These findings underscore the importance of person-
alizing target MAP based on individual patient’s clinical 
response. There is no “one-size fits all” when it comes to 
optimal MAP for septic shock patients. This may seem to 
be an obvious conclusion, since MAP is not organ per-
fusion pressure, as described above. In fact, organ perfu-
sion pressure is highly heterogeneous, not only between 
patients, but also within the same patient over time and 
among their organs and microcirculation during the evo-
lution of septic shock [6, 7]. This is what makes blood 
pressure management in septic shock, particularly chal-
lenging, requiring close bedside titration.
After the SEPSISPAM study was published, two review 
articles were published analyzing blood pressure targets 
for septic shock patients. Leone et al. reviewed 12 studies 
including 7 comparative studies that addressed different 
blood pressure goals on patient outcomes [30]. They con-
cluded that MAP target of 65 mmHg is usually sufficient 
in patients with septic shock, but MAP target of around 
75–85 mmHg may reduce the incidence of acute kidney 
injury (AKI) in patients with chronic hypertension.
D’Aragon et al. also reviewed 12 studies including two 
randomized control studies, which were the SEPSISPAM 








Fig. 2 Theoretical vascular pressure profile from aortic values 
through the circulation to the great veins. Note that mean arterial 
pressure (MAP) is constant for most of the length of the large arteries, 
because those vessels serve mainly as vascular capacitors holding 
stored blood under pressure. Whereas vascular pressure drops rapidly 
as blood traverses the smallest arteries, arteriole and precapillary 
sphincters. The point at which arterioles spontaneously collapse limit-
ing arterial pressure drop is referred to as the critical closing pressure 
(Pcc) and approximates a vascular waterfall, in that water flowing over 
a waterfall is unaffected by how far it falls once over the edge. Thus, 
shown as a dashed line, the pressure fall from arterioles to venules; 
changes in the downstream venous pressure do not influence either 
arterial pressure or blood flow. While the mean systemic filling pres-
sure (Pmsf ) represents the upstream pressure driving venous return 
against a downstream central venous pressure (CVP). These concepts 
were recently validated in post-operative humans where Pcc was esti-
mated to be about 40 mmHg and Pmsf at 20 mmHg [14]
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study and a Czech study, and 10 crossover studies [31]. 
They refrained from making any conclusions regarding 
optimal target blood pressure and commented instead on 
the paucity of clinical evidence to guide blood pressure 
management in septic shock patients. They were particu-
larly concerned with prior studies for using limited types 
of vasopressors, potential inaccuracies on blood pressure 
measurements and titration of vasopressors based on 
endpoints other than blood pressure. Their concerns may 
be justified. Practitioners and researchers tend to disa-
gree even on such a fundamental practice as measuring 
an MAP [32].
The issue of vasopressor choice needed to support 
a given target MAP is also relevant to this discussion. 
It had been suggested that dopamine might increase 
splanchnic blood flow in well-resuscitated patients with 
septic shock [33], but SOAP II study failed to show this 
[29]. In that study, they compared dopamine to norepi-
nephrine in the management of vasopressor-dependent 
septic shock. Although they showed no mortality differ-
ence between the two study arms, the group receiving 
dopamine had a higher rate of arrhythmias and many 
patients in that group also required supplemental norepi-
nephrine to reach their target MAP goals. Based on these 
data, the authors and the Surviving Sepsis Guidelines 
both recommend norepinephrine as the vasopressor of 
choice. Likewise, it had been suggested that vasopres-
sin might impair hepato-splanchnic blood flow [34]. As 
such, VASST trial studied the addition of vasopressin to 
usual vasopressor management. They showed no differ-
ences in the rate of hepatic dysfunction or mesenteric 
ischemia [28]. A smaller prospective randomized study 
even showed better splanchnic perfusion with vasopres-
sin as compared to norepinephrine alone [35]. Currently, 
another trial is underway, comparing vasopressin with or 
without corticosteroids to norepinephrine as the initial 
vasopressor in the management of patients with septic 
shock [36].
Meanwhile, it has been suggested that vasodilators 
such as prostacyclin may improve hepato-splanchnic cir-
culation [35]. In a small prospective study involving sep-
tic shock patients requiring norepinephrine to maintain 
MAP above 70  mmHg, prostacyclin (PGI2 or iloprost) 
infusion showed improvement in both cardiac output 
and hepato-splanchnic blood flow [37]. Notably, the 
actual median MAP was around 80 mmHg in this study.
Organ‑specific blood flow considerations
Brain
As early as the time of Hippocrates more than 2500 years 
ago, sepsis has been known to affect brain function 
[38]. Sepsis-associated delirium is the most common 
brain dysfunction and it can be found in up to 70  % of 
septic patients [38, 39]. It is associated with a significant 
increase in mortality [40, 41].
Cerebral perfusion pressure (CPP) is defined as the 
difference between MAP and either CVP or intracranial 
pressure (ICP), whichever is higher. Under normal condi-
tions, the brain maintains a high degree of autoregulation 
[8]. Notably, in patients with preexisting cerebrovascular 
conditions such as chronic hypertension, the autoregu-
lation threshold is shifted significantly to the right by as 
much as 20 mmHg (Fig. 3) [42].
A study using transcranial Doppler and near-infrared 
spectroscopy showed that cerebral autoregulation is 
disturbed in severe sepsis, presumably due to vascu-
lar endothelial dysfunction [43]. Cerebral blood flow is 
also reduced in severe sepsis [44]. Although its precise 
mechanism is yet to be understood, Pfister et al. demon-
strated that sepsis-induced cerebral edema can increase 
ICP to more than 15 mmHg, resulting in CPP less than 
60 mmHg [45].
There are no clinical studies looking specifically at 
optimal MAP for the brain in severe sepsis, but a grow-
ing body of evidence looking at the relationship between 
CPP and outcomes in patients with traumatic brain 
injury (TBI) may prove helpful. Based on multiple indices 
such as brain tissue O2 saturation, jugular venous oxygen 
saturation, transcranial Doppler and cerebral microdialy-
sis studies, autoregulation threshold for CPP is thought 
to be around 50–60 mmHg [46, 47].




50 mmHg 70 mmHg 
Hypertensive Paents 
Normal Paents
Fig. 3 Theoretical relationship between cerebral perfusion pressure 
(CPP) and cerebral blood flow using the same construct as in Fig. 1. 
Here, the autoregulatory range for subjects without hypertension 
(normal patients) is in blue and that for patients with hypertension 
(hypertensive patients) is shown in gray. Note that the minimal 
CPP within the autoregulatory zone for normal is about 50 mmHg 
whereas for those with hypertension it is shifted rightward with CPP 
on the x-axis to 70 mmHg. Again the maximal vasoconstriction and 
vasodilation instantaneous CCP-cerebral blood flow relations for 
normal patients are shown as the light blue lines
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Accordingly, Brain Trauma Foundation recommends a 
target CPP between 50 and 70  mmHg [48]. Within this 
range, however, results of the existing studies are con-
flicting. For example, one retrospective study involving 
392 patients with severe brain injury showed the poor 
outcome associated with CPP below 60  mmHg [49], 
while another retrospective study involving 427 patients 
with severe head injury showed no benefit in keeping 
CPP above 60 mmHg [50].
One exciting development in the management of CPP 
in TBI patients is the emergence of autoregulation-based 
therapy using cerebrovascular reactivity, which can be 
determined by looking at response of ICP to changes in 
MAP [51]. Loss of cerebrovascular reactivity is an inde-
pendent predictor of fatal outcome following head injury 
[52]. Using real-time measurements of pressure reac-
tivity index, Steiner et  al. found a target CPP in head 
injury patients to be between 60 and 85 mmHg [51]. The 
autoregulation range of an individual patient is much 
narrower, however [53]. Accordingly, the importance of 
titrating a target CPP based on pressure vascular reactiv-
ity index in individual TBI patients was suggested [54]. A 
similar approach that targets autoregulation rather than 
an MAP may also be useful in septic shock patients.
Heart
Sepsis-induced myocardial depression is common and 
it tends to appear later in the course of the disease. Ini-
tially, patients with severe sepsis present with reduced 
CO, despite the preserved left ventricular ejection frac-
tion because stroke volume is reduced as a result of 
decreased preload and vasomotor tone [55, 56]. Both 
these processes cause venous return to the heart to mark-
edly decrease. Volume resuscitation is critical in these 
patients and usually restores stroke volume to baseline 
and CO to baseline or even higher levels owing to a com-
bined tachycardia and peripheral vasodilation.
Later in their course, typically within the first 72  h, 
40–50  % of these patients develop myocardial depres-
sion [57]. Their CO, however, is often increased because 
the reduction in left ventricular ejection fraction is com-
pensated by tachycardia and dilated ventricles [58]. Sep-
sis-induced myocardial depression is reversible and full 
recovery of cardiac function is typically seen in survivors 
by 7–10 days [59].
Pathophysiology of sepsis-induced myocardial depres-
sion is complicated and involves various mechanisms, 
such as downregulation of β-adrenergic receptors, 
decreased sensitivity to calcium or increased nitric oxide 
production [58, 60–62]. Notably, ischemia is not one of 
the etiologies listed. Coronary blood flow is increased 
in severe sepsis and myocardial oxygen consumption 
appears to be adequate [56, 63, 64]. Neither cellular 
hypoxia nor bioenergetics failure has been seen in a sep-
tic heart [65].
These findings led to a hypothesis that perhaps sepsis-
induced myocardial depression is an adaptive response 
by which human heart attempt to prevent activation of 
cell death pathways and to allow full functional recovery 
by reducing energy expenditure [66].
If that would be the case, the best management of heart 
in sepsis may be to avoid further stresses on the heart. 
Interestingly, recent randomized control trial showed 
improved clinical outcome using β-blockers in septic 
shock patients [67]. While its exact mechanism remains 
unknown, the trial showed that β-blockade could make 
the heart more efficient, as evidenced by improved stroke 
work index and left ventricular stroke work [68]. This is 
an area of active clinical study.
Kidneys
Renal function may be the most studied with regard to 
target blood pressure in patients with severe sepsis or 
septic shock. Early animal study by Robertson et al. had 
shown that autoregulation threshold of kidneys might be 
around 80  mmHg [69]. At least two subsequent human 
studies seemed to confirm this by showing improved 
creatinine clearance in septic shock patients whose base-
line MAP below 60  mmHg was raised above 80  mmHg 
using norepinephrine [70, 71]. Looking specifically at 
urine output, however, LeDoux et al. showed that raising 
MAP from baseline 65 mmHg to 85 mmHg using norepi-
nephrine conferred no benefit [21]. This finding was con-
firmed by a small prospective randomized control study 
by Bourgoin et al. involving 28 patients [22]. These clini-
cal studies implied that autoregulation threshold of kid-
neys may be closer to 65 mmHg than 80 mmHg.
More recent studies seemed to favor somewhere in 
the middle. A larger, but retrospective clinical study by 
Dünser et  al. showed that MAP below 75  mmHg was 
associated with a higher requirement of renal replace-
ment therapy [23]. Notably, 38  % of the study popula-
tion had chronic arterial hypertension. Badin et  al. also 
showed in their prospective cohort study that optimal 
MAP to prevent AKI was somewhere between 72 mmHg 
and 82  mmHg [24]. Prevalence of chronic hypertension 
in their study was not reported. Another large prospec-
tive observational study by Poukkanen et  al. suggested 
that MAP below 73 mmHg was associated with progres-
sion of AKI [25]. Nearly half of their study population 
had chronic hypertension and the overall rate of AKI was 
high at 36.2 %.
In elderly patients or patients with hypertension, ath-
erosclerosis or chronic kidney diseases, the autoregu-
lation curve of kidneys can be shifted significantly to 
the right [72, 73]. This may be why the above studies 
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showed benefit of higher MAP to prevent AKI when 
the study cohort included many patients with chronic 
hypertension.
To confirm this, Asfar et al. stratified their study popu-
lation at the time of randomization according to whether 
or not they had a history of chronic hypertension [5]. 
More than 40  % of the study population had chronic 
hypertension. Indeed, they found that among the patients 
with chronic hypertension, the low-MAP target group 
had a significantly higher rate of doubling of creatinine 
or need for renal replacement therapy, compared to the 
high-MAP target group.
Notably, what is missing in all of these studies is the 
consideration of IAP. The renal perfusion pressure 
becomes the difference between MAP and IAP when IAP 
exceeds CVP. IAP can be measured at the bedside using 
bladder pressure [74, 75]. IAH is defined as a sustained 
elevation of IAP above 12  mmHg whereas normal IAP 
is considered to be approximately 5–7 mmHg [76]. Sus-
tained IAP above 20 mmHg is called abdominal compart-
ment syndrome (ACS) and results in intra-abdominal 
organ dysfunction [76]. Thus, in case of ACS, such as in 
abdominal sepsis or sepsis associated with liver failure, 
MAP target may need to be increased at least by the 
increase in IAP.
Given the current state of evidence, MAP target of 
65  mmHg may be reasonable in septic shock patients 
without any heightened susceptibility to AKI, such 
as preexisting chronic hypertension, atherosclerosis, 
chronic kidney disease or advanced age. In contrast, 
septic shock patients with these risk factors may ben-
efit from higher target MAP of 80  mmHg. In patients 
with IAH, further increase in MAP target may be nec-
essary, depending on their IAP. Notably, multiple other 
conditions including the use of medications such as 
nonsteroidal anti-inflammatory drugs can also impair 
kidney’s autoregulation and may benefit from higher 
MAP.
Vasopressor of choice to achieve desired MAP is nor-
epinephrine. Norepinephrine reduces renal blood flow 
in normal condition, but increases in sepsis by both 
decreasing renal vascular resistance and Pcc [77]. Vaso-
pressor should be used with caution, however, because 
of its potential complications as mentioned above. This 
point may be particularly important because an increas-
ing body of evidence suggests that hypotension, though 
important, may not be the primary cause of sepsis-asso-
ciated AKI [78]. Schlichtig et  al. showed that kidneys 
could tolerate significant hypotension compared to rest 
of the body [79]. In a large retrospective cohort study, 
Murugan et  al. found that sepsis-associated AKI can 
occur in the absence of global hypotension [80]. Resto-
ration of hemodynamic variables alone thus should not 
be the only goal for the management of sepsis-associated 
AKI [81].
Liver
The liver plays a critical role in severe sepsis and septic 
shock for two reasons [82]. First, the entire splanchnic 
circulation, which comprises 25  % of cardiac output, 
must pass through the liver. This is particularly impor-
tant because the gastrointestinal tract is thought to be 
the driver of multi-organ failure syndrome in sepsis [83]. 
Second, nearly 90  % of the body’s reticuloendothelial 
system exists within the liver, primarily as Kupffer cells 
[82]. Thus, the liver is thought to be the clearinghouse 
of microbial pathogen-associated molecular patterns 
(PAMPs) and endogenous “damage”-associated molecu-
lar patterns (DAMPs) that incite and perpetuate systemic 
inflammatory response [84].
Unlike the other organs, but like the lungs, the liver 
receives both arterial and venous blood flow. Hepatic 
artery supplies 25–50 % of hepatic blood flow and portal 
vein supplies the remainder [85]. Regulation of hepatic 
arterial flow and portal venous flow is distinct from each 
other. Autoregulation is the primary mechanism for the 
arterial system, while distensibility of vascular beds that 
create capacitance and existence of vascular waterfall in 
the portal venous system allows steady venous return 
despite changes in CVP [86, 87]. Furthermore, any reduc-
tion in portal venous flow is mitigated by a reciprocal 
increase in hepatic arterial blood flow. This mechanism is 
called hepatic arterial buffer response and appears to be 
mediated by adenosine [88].
Severe sepsis affects the liver in two stages [89]. In 
the first hours, early hepatic dysfunction occurs due to 
hypoperfusion. Both autoregulation of hepatic artery and 
hepatic buffer response appear to be impaired [90]. This 
is followed by late hepatic dysfunction, characterized by 
functional and structural injury due to various circulating 
PAMPs and DAMPs.
Often, hepatic and splanchnic circulations are studied 
together due to technical difficulties in isolating one from 
another [33], and studies specifically looking at optimal 
MAP for hepato-splanchnic circulation in septic shock 
are limited. In Asfar et  al., there was no difference in 
the rate of mesenteric ischemia between the low-target 
group and the high-target group (2.3 versus 2.3 %) [4]. A 
study that showed the lowest rate of bowel ischemia was 
the SOAP II study, which compared dopamine versus 
norepinephrine for the treatment of septic shock (1.3 ver-
sus 0.7 %) [29]. Notably, the actual MAP was maintained 
only around 58 mmHg in this study. In other studies that 
compared various regimens of vasopressors and their 
impact on hepato-splanchnic circulation, the actual MAP 
was maintained at least above 70 mmHg [33].
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Conclusion
The available evidence suggests that targeting an MAP 
of 65–70  mmHg in a patient with septic shock who 
does not have chronic hypertension is a reasonable first 
approximation. Whereas in a patient with chronic hyper-
tension, targeting an MAP of 80–85  mmHg appears to 
be a reasonable first step. It must be done with caution, 
however, because the use of vasopressors is associated 
with adverse events. After these initial treatments, MAP 
should be titrated up or down based on the individual 
patient’s response, but heterogeneity, not only of patients, 
but of organs and microcirculations affected by septic 
shock makes it challenging. Caution needs to be taken 
in all patients in using MAP alone as surrogate of organ 
perfusion pressure, especially under conditions in which 
intracranial or intra-abdominal pressure may be elevated.
If sepsis-associated delirium is the primary concern, 
a growing body of evidence regarding the management 
of traumatic brain injury patients suggests that MAP 
target between 50 and 70  mmHg is needed. Further 
titration of MAP based on multi-modal monitoring 
including pressure-reactivity index may worth further 
investigation.
Sepsis-induced myocardial depression, though chal-
lenging in its management, may be an adaptive response 
by the heart in sepsis. Because coronary blood flow is 
increased, MAP target should not guide its management. 
Rather, it is important not to stress the heart any further 
by avoiding excessive or prolonged use of vasopressors. 
Recent study suggests promising role of β-blockers.
Target MAP in septic shock is most studied in relation 
to sepsis-associated AKI. In patients without chronic 
hypertension, atherosclerosis, chronic kidney disease or 
advanced age, MAP target of 65 mmHg may be reason-
able. For patients with these risk factors, MAP target of 
80  mmHg may be better. It should be noted, however, 
that recent evidence suggests that hypotension may not 
be the primary mechanism of sepsis-associated AKI.
Finally, hepatic dysfunction or mesenteric ischemia 
that can be associated with septic shock may not only 
result from the disease, but also from excessive use of 
vasopressors. MAP target as low as 60  mmHg may be 
reasonable to reduce vasopressor requirement. Further-
more, there may be a role of vasodilator in the manage-
ment of hepato-splanchnic blood flow.
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